In a Friday interview with CNBC's Jim Cramer, Recursion Pharmaceuticals CEO Chris Gibson discussed how his company is using artificial intelligence and machine learning to create new drugs. Recursion ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback